REQUEST A DEMO
Total
USD $0.00
Search more companies

Biotecno Zf Sas (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Biotecno Zf Sas Profile Updated: April 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Biotecno Zf Sas is a company based in Colombia, with its head office in Tocancipa. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. Biotecno Zf Sas was incorporated on November 05, 2015. Biotecno Zf Sas currently employs 25 (2025) people. In 2024, the company reported a net sales revenue increase of 19.45%. A growth of 45.65% was recorded in its total assets. The net profit margin of Biotecno Zf Sas increased by 1.77% in 2024.

Headquarters
Vrd Tibito Zf Tocancipa Km 1 5 Briceno Zipaquira Bg 13 A Mz 3
Tocancipa; Cundinamarca;

Contact Details: Purchase the Biotecno Zf Sas report to view the information.

Basic Information
Total Employees:
Purchase the Biotecno Zf Sas report to view the information.
Registered Capital:
Purchase the Biotecno Zf Sas report to view the information.
Financial Auditors:
Purchase the Biotecno Zf Sas report to view the information.
Incorporation Date:
November 05, 2015
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Biotecno Zf Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
19.45%
Total operating revenue
10.8%
Operating profit (EBIT)
28.65%
EBITDA
28.23%
Net Profit (Loss) for the Period
29.27%
Total assets
45.65%
Total equity
29.83%
Operating Profit Margin (ROS)
2.15%
Net Profit Margin
1.77%
Return on Equity (ROE)
-0.28%
Debt to Equity Ratio
-1.5%
Quick Ratio
-0.14%
Cash Ratio
0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?